特斯拉、苹果、阿里、百度集体拉升，减肥药企暴涨超60%，金价创新高

Group 1: Stock Market Performance - The US stock market showed mixed performance with the Dow Jones up 0.05%, Nasdaq up 0.31%, and S&P 500 up 0.18% as of September 22 [1] - Tesla's stock rose nearly 3.6% after several institutions raised their target prices, with Baird upgrading its rating to "outperform" and predicting a price of $3000 by 2035 [1] - Alibaba's stock increased by nearly 1%, supported by a report from Citigroup highlighting a new in-store group buying promotion coinciding with the travel peak season [1] - Apple saw a rise of over 3%, reaching an 8-month high, with Wedbush Securities setting the highest target price on Wall Street at $310 [1] Group 2: Company Developments - Baidu's stock rose over 4% following the launch of its new visual understanding model Qianfan-VL, which is optimized for enterprise-level multimodal applications [3] - Metsera, a developer of anti-obesity drugs, saw its stock surge over 60% amid reports that Pfizer is nearing a deal to acquire the company for up to $7.3 billion [4][5] Group 3: Economic Indicators and Market Sentiment - The Federal Reserve's recent interest rate cut of 25 basis points has led to increased expectations of further cuts, which is a key driver behind the recent highs in the US stock market [7][8] - Concerns are rising regarding the US long-term treasury market performance and potential budget battles in Congress, which could impact market confidence [7][8] - Gold prices reached a new high of $3728 per ounce, driven by multiple factors including the Fed's rate cut and weak economic data [10][15]